These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23414979)

  • 1. "How high do they look?": identification and treatment of common ingestions in adolescents.
    Woo TM; Hanley JR
    J Pediatr Health Care; 2013; 27(2):135-44. PubMed ID: 23414979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current "legal highs".
    Johnson LA; Johnson RL; Portier RB
    J Emerg Med; 2013 Jun; 44(6):1108-15. PubMed ID: 23528960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells.
    Rosas-Hernandez H; Cuevas E; Lantz SM; Rice KC; Gannon BM; Fantegrossi WE; Gonzalez C; Paule MG; Ali SF
    Neurosci Lett; 2016 Aug; 629():125-130. PubMed ID: 27320055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health Implications.
    White CM
    J Clin Pharmacol; 2016 Nov; 56(11):1319-1325. PubMed ID: 27029951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.
    Miner NB; O'Callaghan JP; Phillips TJ; Janowsky A
    Neurotoxicol Teratol; 2017 May; 61():74-81. PubMed ID: 28212938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jan; 208(1):12-5. PubMed ID: 22008731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focus on Adolescent Use of Club Drugs and "Other" Substances.
    Williams JF; Lundahl LH
    Pediatr Clin North Am; 2019 Dec; 66(6):1121-1134. PubMed ID: 31679602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces.
    Loeffler G; Hurst D; Penn A; Yung K
    Mil Med; 2012 Sep; 177(9):1041-8. PubMed ID: 23025133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Illicit bath salts: not for bathing.
    Kyle PB; Iverson RB; Gajagowni RG; Spencer L
    J Miss State Med Assoc; 2011 Dec; 52(12):375-7. PubMed ID: 22329114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clean but not sober: a 16-year-old with restlessness.
    Osterhoudt KC; Cook MD
    Pediatr Emerg Care; 2011 Sep; 27(9):892-4. PubMed ID: 21926895
    [No Abstract]   [Full Text] [Related]  

  • 11. Designer drugs in psychiatric practice - a review of the literature and the recent situation in Hungary.
    Szily E; Bitter I
    Neuropsychopharmacol Hung; 2013 Dec; 15(4):223-31. PubMed ID: 24380963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic cathinones in Southern Germany - characteristics of users, substance-patterns, co-ingestions, and complications.
    Romanek K; Stenzel J; Schmoll S; Schrettl V; Geith S; Eyer F; Rabe C
    Clin Toxicol (Phila); 2017 Jul; 55(6):573-578. PubMed ID: 28347165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic drugs of abuse.
    Tamama K
    Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.
    Kiyatkin EA; Ren SE
    Curr Top Behav Neurosci; 2017; 32():183-207. PubMed ID: 27677782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are "bath salts" the next generation of stimulant abuse?
    Winder GS; Stern N; Hosanagar A
    J Subst Abuse Treat; 2013 Jan; 44(1):42-5. PubMed ID: 22445773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts.
    Zhou X; Luethi D; Sanvee GM; Bouitbir J; Liechti ME; Krähenbühl S
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in designer drug abuse.
    Crews BO; Petrie MS
    Clin Chem; 2015 Jul; 61(7):1000-1. PubMed ID: 26322357
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: "Spice, bath salts, and the U.S. Military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces".
    Platteborze PL; Martin TM
    Mil Med; 2013 Jan; 178(1):v. PubMed ID: 23356108
    [No Abstract]   [Full Text] [Related]  

  • 19. Bath salts: they are not what you think.
    Wieland DM; Halter MJ; Levine C
    J Psychosoc Nurs Ment Health Serv; 2012 Feb; 50(2):17-21. PubMed ID: 22439144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic cathinone adulteration of illegal drugs.
    Oliver CF; Palamar JJ; Salomone A; Simmons SJ; Philogene-Khalid HL; Stokes-McCloskey N; Rawls SM
    Psychopharmacology (Berl); 2019 Mar; 236(3):869-879. PubMed ID: 30338489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.